Targeted interleukin 8 (IL-8 or CXCL8) for treating endometriosis

Szu-Ting Yang, Yang ST, Chang WH, Wen-Hsun Chang, Huang HY, Hong-Yuan Huang, Peng‐Hui Wang, Wang PH, Peng-Hui Wang
Taiwanese journal of obstetrics & gynecology · 2026 · vol. 65(5) , pp. 885–887 · doi:10.1016/j.tjog.2026.06.002 · PMID:42642142 · W7204207422
editorial OA: diamond public-domain-us
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This paper explores the potential of targeting interleukin 8 (IL-8 or CXCL8) as a therapeutic strategy for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Source provenance

europepmc
last seen: 2026-09-02T06:13:17.951775+00:00
openalex
last seen: 2026-09-02T06:04:46.041018+00:00
pubmed
last seen: 2026-09-02T06:06:27.904058+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine